Hunan Qiankang Technology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hunan Qiankang Technology Co., Ltd. - overview
Established
2014
Location
Changsha, Hunan, China
Primary Industry
Medical Devices & Equipment
About
Established in 2014 and based in Changsha, China, Hunan Qiankang Technology Co. , Ltd. operates as a medical device developer focuses on the development of testing equipment. In October 2019, the firm closed a series A funding.
As of September 2024, the company has obtained more than 160 intellectual property rights, including more than 10 PCT international patents. It has obtained ISO:13485 quality management system certification, ISO:13485 quality management system certification and other certificates. The company's main products include urine beta-amyloid protein detection kits, chemiluminescence detection reagents and traditional Chinese medicine capsules. The urine beta-amyloid protein detection kit uses colloidal gold immunochromatography technology to qualitatively detect the AB concentration level in human urine.
The company's products are used in areas such as Alzheimer's disease and cardiovascular and cerebrovascular diseases. The company’s revenue is generated by providing medical devices.
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment
Website
www.hnqkkj.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.